Latest News for: dose

Edit

'Prepare Sooryavanshi For Failure': India Told To Give Vaibhav Dose Of Reality

News18 18 Jun 2026
As Vaibhav Sooryavanshi deals with his rapid rise and fame, Paddy Upton has advised the Indian team management to keep the young star grounded and prepared for failures ....
Edit

Wegovy pill in UAE: Prices, doses and why first-time users are showing interest

Khaleejtimes 18 Jun 2026
The 9mg dose costs Dh1,199, while the 25mg dose is priced at Dh1,610 ... Follow KT on WhatsApp Channels.Which doses are available? ... At International Modern Hospital Dubai, all the four doses like 1.5mg, ...
Edit

PleoPharma, Inc. Announces First Patient Dosed in Pivotal Phase 3 Clinical Trial of PP-01 (CAN-004) for Mitigation of Cannabis Withdrawal Symptoms in Patients with Cannabis Use Disorder

PR Newswire 18 Jun 2026
... been dosed in CAN-004, a Phase 3 clinical trial evaluating PP-01, an investigational medication intended for the mitigation of cannabis withdrawal symptoms in adults with cannabis use disorder (CUD).
Edit

Verastem Oncology Doses First Patient in TARGET-D 201 Phase 2 Registration-Directed Trial of VS-7375 Oral ...

Norfolk Daily News 17 Jun 2026
TARGET-D 201 trial to evaluate VS-7375 both as monotherapy and in combination with cetuximab for second-line treatment ... .
Edit

Chad Merrill | Front could bring dose of gusty winds to region Thursday

Cumberland Times News 17 Jun 2026
An unseasonably strong low pressure traversing the Great Lakes on Thursday will bring a widespread high wind event to Western Maryland and the Potomac Highlands ... .
Edit

June 17, 2026 - FDA Approves First Single-Dose Generic Treatment for Influenza (FDA - Food and Drug Administration)

Public Technologies 17 Jun 2026
Food and Drug Administration today approved the first generic of Xofluza (baloxavir marboxil) tablets, the first single-dose treatment for acute uncomplicated influenza and prophylaxis in patients 5 years of age and older.
Edit

Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969, Achieving First Clinical Milestone in Collaboration with Hygtia Therapeutics

PR Newswire 17 Jun 2026
The data collected from this study are expected to provide critical evidence to inform dose selection and support therapeutic relevance in future clinical development.
Edit

ConSynance Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of CSTI-500 for Prader-Willi Syndrome

Nasdaq Globe Newswire 16 Jun 2026
First patient dosed in FPWR-supported Phase 2a trial of CSTI-500 for hyperphagia and neurobehavioral symptoms in PWS ... .
Edit

First human dosed with cellular reprogramming drug in longevity trial

The Washington Times 16 Jun 2026
A Boston biotech company has administered what researchers are describing as the first human dose of a cellular rejuvenation drug, a milestone in the effort to treat age-related disease at the epigenetic level ... .
Edit

Comprehensive Healthcare implements ZING� robot for methadone dosing

Nasdaq Globe Newswire 16 Jun 2026
Comprehensive Healthcare announces the successful implementation of ZING�, a robotic methadone dosing assembly system, at its clinic in Yakima, Washington ... .
×